.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Colorcon
Queensland Health
AstraZeneca
Daiichi Sankyo
Farmers Insurance
Healthtrust
Chinese Patent Office
Federal Trade Commission
US Army

Generated: July 27, 2017

DrugPatentWatch Database Preview

MELFIAT Drug Profile

« Back to Dashboard

Which patents cover Melfiat, and when can generic versions of Melfiat launch?

Melfiat is a drug marketed by Numark and is included in two NDAs.

The generic ingredient in MELFIAT is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for Tradename: MELFIAT

Patents:0
Applicants:1
NDAs:2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MELFIAT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Numark
MELFIAT
phendimetrazine tartrate
TABLET;ORAL083790-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Numark
MELFIAT-105
phendimetrazine tartrate
CAPSULE, EXTENDED RELEASE;ORAL087487-001Oct 13, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Chubb
Fuji
Teva
Cipla
McKesson
Citi
Harvard Business School
Merck
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot